Testing effectiveness (Phase 2)UnknownNCT06334367What this trial is testingProphylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCTWho this might be right forGVHD Wang Xin 40
Early research (Phase 1)Study completedNCT01403792What this trial is testingA Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female SubjectsWho this might be right forHuman Immunodeficiency Virus University of Surrey 11
Testing effectiveness (Phase 2)Study completedNCT01417936What this trial is testingSym004 in SCCHN Patients Failing Anti-EGFR Based TherapyWho this might be right forCarcinoma, Squamous Cell of Head and Neck Symphogen A/S 26
Early research (Phase 1)Study completedNCT00072592What this trial is testingAn Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard TherapiesWho this might be right forWegener's Granulomatosis National Institute of Allergy and Infectious Diseases (NIAID) 10
Post-approval studies (Phase 4)Ended earlyNCT01246011What this trial is testingSignificance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft OcclusionWho this might be right forCoronary Artery Bypass Graft SurgeryPresence of Heparin/Platelet Factor 4 Antibody Massachusetts General Hospital 9
Early research (Phase 1)Study completedNCT02564900What this trial is testingStudy of DS-8201a in Subjects With Advanced Solid Malignant TumorsWho this might be right forAdvanced Solid Tumors Daiichi Sankyo Co., Ltd. 292
Testing effectiveness (Phase 2)Study completedNCT00563836What this trial is testingPhase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian CancerWho this might be right forOvarian CancerEpithelial Ovarian Cancer Neovii Biotech 41
Testing effectiveness (Phase 2)Study completedNCT01164007What this trial is testingBevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Study completedNCT01031836What this trial is testingEvaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.Who this might be right forSystemic Lupus Erythematosus AstraZeneca 30
Early research (Phase 1)Looking for participantsNCT06598800What this trial is testingStudy of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor BeOne Medicines 153
Not applicableStudy completedNCT03180892What this trial is testingNon-immune Related Hypothyroidism in Iodine Sufficient AreaWho this might be right forHypothyroidism Samsung Medical Center 6,564
Testing effectiveness (Phase 2)Study completedNCT01160744What this trial is testingPemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Eli Lilly and Company 280
Large-scale testing (Phase 3)Study completedNCT00465985What this trial is testingEfficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells SyndromeWho this might be right forMuckle Wells Syndrome Novartis 35
Large-scale testing (Phase 3)Ended earlyNCT00676143What this trial is testingStudy Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 1,100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208What this trial is testingPD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyWho this might be right forHepatocellular Carcinoma (HCC) Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02336815What this trial is testingSelinexor Treatment of Refractory MyelomaWho this might be right forMultiple Myeloma Karyopharm Therapeutics Inc 202
Large-scale testing (Phase 3)UnknownNCT03794440What this trial is testingEvaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.Who this might be right forHepatocellular Carcinoma Innovent Biologics (Suzhou) Co. Ltd. 595
Large-scale testing (Phase 3)Study completedNCT02525874What this trial is testingEffect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).Who this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis Biogen 218
Testing effectiveness (Phase 2)Study completedNCT01258608What this trial is testingStudy of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Human Genome Sciences Inc., a GSK Company 101
Early research (Phase 1)WithdrawnNCT05381935What this trial is testingES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumor Elpiscience Biopharma, Ltd.